🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. logo
Market Cap: High
Employees: Medium

ARO-AAT, ARO-APOC3, ARO-ANG3, ARO-HSD, ARO-ENaC, ARO-C3, ARO-Lung2, ARO-DUX4, ARO-XDH

Arrowhead Pharmaceuticals, Inc. develops medicines for intractable diseases, with products including RNAi therapeutics addressing liver diseases, hypertriglyceridemia, and various other conditions in different trial phases.

Tags: RNAi therapeutics, biotechnology, chronic obstructive pulmonary disorder, clinical trials, hypertriglyceridemia, liver disease, pharmaceuticals

Website

About | Leadership | ESG | Contact | Contact | Careers | Careers | ESG | About | About

Symbol: ARWR

Recent Price: $18.61

Industry: Biotechnology

CEO: Dr. Christopher R. Anzalone Ph.D.

Sector: Healthcare

Employees: 525

Address: 177 East Colorado Boulevard, Pasadena, CA 91105

Phone: 626 304 3400

Leadership

  • Christopher Anzalone, PhD,
  • James Hamilton, MD, MBA, Chief of Discovery and Translational Medicine
  • Ken Myszkowski, MBA, CPA, Chief Financial Officer
  • Patrick O’Brien, PharmD, JD, Chief Operating Officer and General Counsel
  • Tracie Oliver, MSc, MBA, Chief Commercial Officer
  • Douglass Given, MD, PhD, MBA, Chairman
  • Mauro Ferrari, PhD,
  • Michael Perry, DVM, PhD,
  • William Waddill,
  • Oye Olukotun, MD, MPH,
  • Victoria Vakiener,
  • Hongbo Lu, PhD, MBA,

Last updated: 2024-12-31